Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

New fat jab warning as pregnancy risks revealed, even after stopping use – from ‘premature birth to extra weight gain’

FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such ...
Becker's Hospital Review

Telehealth companies push GLP-1s beyond approved use

Telehealth companies are promoting GLP-1 medications such as Ozempic and Wegovy for cosmetic weight loss in non-obese patients, despite FDA limitations on their approved use, according to a Nov. 24 ...

Weight-Loss Drugs Don’t Appear to Work Against Alzheimer’s

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...
KNPR

5 things to know about the new obesity pills that are on the way

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Eli Lilly Becomes First Trillion-Dollar Health Company

MONDAY, Nov. 24, 2025 (HealthDay News) — Eli Lilly reached a major milestone Friday, becoming the first healthcare company in ...

Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the ...

Transcript: How Ireland became the weak spot in Europe’s defences

Aanu Adeoye So, Bayer’s drug called asundexian is intended for people who have suffered something called a non-cardioembolic stroke, or people who have suffered a mini stroke, because people who have ...